17 results
P
Wilson disease
I/C
R778L mutation, no R778L mutation
O
earlier presentation, lower ceruloplasmin concentration
P
patients with Wilson disease (WD)
I/C
systematic review and meta-analysis of the association between WD and prevalent sleep disorders, control patients
O
sleep disorders, insomnia, rapid eye movement (REM) sleep behavior disorder (RBD), excessive daytime sleepiness (EDS), sleep-disordered breathing (SDB), restless legs syndrome (RLS), periodic limb movement in sleep (PLM), cataplexy-like episodes (CLEs), sleep paralysis, objective sleep characteristics
P
hyperthyroidism
I/C
Jiawei-Xiaoyao-San (JWXYS), antithyroid drugs (ATDs)
O
free triiodothyronine (FT3), free thyroxine (FT4), thyroid stimulating hormone (TSH), effectiveness rate, goiter score, thyrotrophin receptor antibody, adverse events
P
patients with poststroke depression
I/C
modified Sini San (MSS), fluoxetine hydrochloride
O
response rate, Hamilton depression rating scale (HAMD) scores, modified Edinburgh-Scandinavia stroke scale (SSS) scores
P
1335
I/C
Shen-ling-bai-zhu san (SLBZS), conventional therapies
O
superior
P
primary breast cancer (BC) patients
I/C
hormone therapy (HT), NON-HT BC patients, NORMAL participants
O
developing diabetes mellitus (DM)
P
African Americans, White population, Hispanic group
I/C
high temperatures, lower temperatures
O
kidney disease-related hospital admissions
P
Hispanic populations
I/C
gut microbiota related metabolites, measures of glycemia, dyslipidemia, adiposity, and incident type 2 diabetes
O
cross-sectional and longitudinal relationships
P
Patients with hepatocellular carcinoma (HCC)
I/C
Liver transplantation using different selection models: Milan, UCSF, UPTS, AFP, and MT2
O
Recurrence-free survival and overall survival rates at 1, 3, and 5 years post-transplantation